Trade Summary

1 week ago, Simon Amy, serving as Chief Medical Officer at Beam Therapeutics Inc. (BEAM), sold 16,667 shares at $25.74 per share, for a total transaction value of $429,036.91. Following this transaction, Simon Amy now holds 85,696 shares of BEAM.

This sale represents a 16.28% decrease in Simon Amy's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, July 27, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 29, 2026 at 4:05 PM ET, 2 days after the trade was made.

Beam Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.